Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc logo
CRNX

Crinetics Pharmaceuticals Inc (CRNX)

$17.571.68%

Market is closed
– opens on 8 PM, 02 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$16.91
Day's Range
$17.99
$15.91
52-Week Range
$28.95
1 month return2.44%
3 month return13.11%
1 year return32.35%
5 year return28.31%

Company Information

Crinetics Pharmaceuticals is a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate, paltusotine (formerly CRN00808), is an oral selective nonpeptide somatostatin receptor type 2 biased agonist undergoing two Phase 2 clinical trials for the treatment of acromegaly, an orphan disease affecting more than 25,000 people in the United States. Crinetics plans to advance paltusotine into a Phase 3 trial in acromegaly and a Phase 2 trial for the treatment of carcinoid syndrome associated with NETs in 2021. The company is also developing CRN04777, an oral nonpeptide somatostatin receptor type 5 (SST5) agonist for hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease, congenital adrenal hyperplasia and other diseases of excess ACTH. All of the company's drug candidates are new chemical entities resulting from in-house drug discovery efforts and are wholly owned by the company
OrganizationCrinetics Pharmaceuticals Inc
Employees143
CEODr. R. Scott Struthers Ph.D.
IndustryHealth Technology

Analyst Recommendation

based on 6 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 6 Wall street analysts offering stock ratings for Crinetics Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 144.74%

Current

$17.57

Target

$43.0

Recommendation Trend

Based on 6 analyst

Current1M Ago3M Ago
Buy
6
12
12
Hold
0
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
961.6M
Book Value
$6.53
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-2.83
Wall Street Target Price
43.0

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
2.61
Enterprise Value
551.4M
Enterprise Value/Revenue
107.98
Enterprise Value/Ebitda
-3.67

Technicals

Beta
1.03
50 Day MA
18.15
200 Day MA
19.58

Institutional Holdings

Driehaus Capital Management LLC

10.47%

Perceptive Advisors LLC

9.89%

Bvf Inc

6.84%

Orbimed Advisors, LLC

5.94%

FMR Inc

5.55%

Wellington Management Company LLP

4.89%

Discover more

Frequently Asked Questions

What is Crinetics Pharmaceuticals Inc share price today?

Can Indians buy Crinetics Pharmaceuticals Inc shares?

How can I buy Crinetics Pharmaceuticals Inc shares from India?

Can Fractional shares of Crinetics Pharmaceuticals Inc be purchased?

What are the documents required to start investing in Crinetics Pharmaceuticals Inc stocks?

What are today’s High and Low prices of Crinetics Pharmaceuticals Inc?

What are today’s traded volumes of Crinetics Pharmaceuticals Inc?

What is today’s market capitalisation of Crinetics Pharmaceuticals Inc?

What is the 52 Week High and Low Range of Crinetics Pharmaceuticals Inc?

How much percentage Crinetics Pharmaceuticals Inc is down from its 52 Week High?

How much percentage Crinetics Pharmaceuticals Inc is up from its 52 Week low?

What are the historical returns of Crinetics Pharmaceuticals Inc?

Who is the Chief Executive Officer (CEO) of Crinetics Pharmaceuticals Inc?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*